HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical efficacy of dexamethasone intravitreal implant (Ozurdex) in patients with retinal vein occlusions].

Abstract
Two cases of dexamethasone intravitreal implant (Ozurdex) use are reported. The drug promotes resolution of macular edema and ensures a long-term improvement of visual acuity. The latter may depend on such factors as the duration of the disease and localization of the occlusion. Application of Dexamethasone Intravitreal Implant provides new opportunities for the treatment of retinal vein occlusions.
AuthorsA V Kulagina, O G Gusarevich, A A Gusarevich, P A Lebedev, A D Baltaks
JournalVestnik oftalmologii (Vestn Oftalmol) 2014 May-Jun Vol. 130 Issue 3 Pg. 49-53 ISSN: 0042-465X [Print] Russia (Federation)
PMID25098123 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Glucocorticoids
  • Dexamethasone
Topics
  • Adult
  • Aged
  • Dexamethasone (administration & dosage)
  • Diagnostic Techniques, Ophthalmological
  • Female
  • Glucocorticoids (administration & dosage)
  • Humans
  • Intravitreal Injections (methods)
  • Macular Edema (diagnosis, drug therapy, etiology, physiopathology)
  • Male
  • Retinal Vein Occlusion (complications, diagnosis, physiopathology)
  • Treatment Outcome
  • Visual Acuity (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: